GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BHVN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Biohaven Pharmaceutical Holding Co Ltd stock price on Friday which ended trading at $38.99
(Updated on Apr 19, 2024)

Sell candidate since Apr 01, 2024 Loss -25.11% PDF

The Biohaven Pharmaceutical Holding Co Ltd stock price fell by -7.52% on the last day (Friday, 19th Apr 2024) from $42.16 to $38.99. During the last trading day the stock fluctuated 14.96% from a day low at $37.61 to a day high of $43.24. The price has fallen in 7 of the last 10 days and is down by -25.76% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -254 thousand shares and in total, 3 million shares were bought and sold for approximately $130.74 million.

Given the current short-term trend, the stock is expected to rise 10.28% during the next 3 months and, with a 90% probability hold a price between $43.00 and $68.57 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BHVN Signals & Forecast

There are few to no technical positive signals at the moment. The Biohaven Pharmaceutical Holding Co Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $45.76 and $53.39. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -34.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Biohaven Pharmaceutical Holding Co Ltd stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $5.63 between high and low, or 14.96%. For the last week, the stock has had daily average volatility of 10.93%.

Biohaven Pharmaceutical Holding Co Ltd is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BHVN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Biohaven Pharmaceutical Holding Company Ltd to open at $39.95, and during the day (based on 14 day Average True Range), to move between $35.60 and $42.38, which gives a possible trading interval of +/-$3.39 (+/-8.69%) up or down from last closing price. If Biohaven Pharmaceutical Holding Company Ltd takes out the full calculated possible swing range there will be an estimated 17.37% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $42.16, some $3.17 (8.13%) from the current price of $38.99, our system finds the risk reward not very attractive.

Is Biohaven Pharmaceutical Holding Company Ltd stock A Buy?

The Biohaven Pharmaceutical Holding Co Ltd stock holds several negative signals and despite the positive trend, we believe Biohaven Pharmaceutical Holding Co Ltd will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.994 Sell Candidate Unchanged

Predicted Opening Price for Biohaven Pharmaceutical Holding Company Ltd of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$39.95 ( 2.45%) $38.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BHVN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 45.57 16.88 %
R2 43.42 11.37 %
R1 42.09 7.96 %
Current price: 38.99
Support S1 37.80 -3.06 %
S2 36.47 -6.47 %
S3 34.32 -11.98 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.77 14.82 %
R2 43.77 12.26 %
R1 42.16 8.13 %
Current price 38.99
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Biohaven Pharmaceutical Holding Company Ltd Stock and on which exchange is it traded?
The symbol for Biohaven Pharmaceutical Holding Company Ltd is BHVN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Biohaven Pharmaceutical Holding Company Ltd Stock?
The Biohaven Pharmaceutical Holding Co Ltd stock holds several negative signals and despite the positive trend, we believe Biohaven Pharmaceutical Holding Co Ltd will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Biohaven Pharmaceutical Holding Company Ltd Stock?
Biohaven Pharmaceutical Holding Company Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biohaven Pharmaceutical Holding Company Ltd Stock.

What's the current price of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the end of day on the 2024-04-19, the price of an Biohaven Pharmaceutical Holding Company Ltd (BHVN) share was $38.99.

What is the 52-week high and low for Biohaven Pharmaceutical Holding Company Ltd Stock?
The 52-week high for Biohaven Pharmaceutical Holding Company Ltd Stock is $62.21 and the 52-week low is $12.37.

What is the market capitalization of Biohaven Pharmaceutical Holding Company Ltd Stock?
As of the 2024-04-19, the market capitalization of Biohaven Pharmaceutical Holding Company Ltd is 3.184B.

When is the next earnings date for Biohaven Pharmaceutical Holding Company Ltd?
The upcoming earnings date for Biohaven Pharmaceutical Holding Company Ltd is May 10, 2024.
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT